Strong Revenue Growth:
Reported $100M in contracted annual recurring revenue by year-end 2025 and rising platform activity indicate accelerating topline momentum. Expanding adoption of AI agents and larger-scale deployments point to growing recurring demand.
Investor Backing & Capital Strength:
A $65M growth investment announced in December 2025 provides fresh capital to accelerate expansion and adoption of the platform. Participation from existing investors underscores continued access to funding for scale initiatives.
Market Expansion:
FedRAMP Class D authorization for a Federal Edition opens pathways into U.S. federal healthcare settings. Materials citing 1,000+ provider organizations and deep EHR ecosystem integrations reflect broad and widening market reach.
.jpg)
.jpg)
